Chang-Ming Yang, M.D., Ph.D., a biomedical engineer and physician, merges electronics and biomedicine at Ming-Young Biochemical (Junan Town). The company's remote health care monitoring systems measure physiological functions such as heart rate, respiration, ECG, body temperature, and blood pressure.
A combination of electronics, fiber chemistry, and biotechnology resulted in an electric-textile shirt that senses vital signs when it touches the skin, says Dr. Yang, president of Ming-Young Biochemical. Patients can wear the shirt-like monitor in hospitals or at home. A portable sleep-quality analyzing system looks like a pillow, but it monitors respiratory rate, snoring, and body movement without disturbing the user's sleep.
Medigen Biotechnology (Gueishan Township) focuses on cancer, and the company has several proprietary technologies. The Rapid Bio-Marker Identification system discovers novel cancer specific genes used for the development of new detection and therapeutic tools.
About 100 cancer-related genes have been identified, and their DNA sequences are being used for gene chip prototypes. Medigen scientists plan to develop specific biochips that will detect cancer and determine the type and stage by using a small amount of blood.
Founded by a group of biomedical scientists in 2000, AbGenomics (Taipei) discovers and develops novel therapeutic Mabs for the treatment of cancer and immune-related inflammatory disorders, including allergies, asthma, and autoimmune illnesses. The company's integrated platform combines the discovery of new gene functions, identification of disease target proteins, and validation of animal disease models.
AbGenomics' goal is to create novel therapeutic Mabs to target disease-causing T cells or cancer cells, while sparing protective T cells and normal cells.
Chien Du-shieng, Ph.D., president and CEO of SunTen Phytotech (Jhonghe City), worked in Big Pharma in the U.S. for 20 years. "I was a skeptic about botanical drugs," he admits. When he returned to Taipei to head SunTen Phytotech, he applied Western drug discovery processes to develop technical platforms that authenticate plant extracts and raw materials.
"Botanical drugs have not been given a fair assessment by the scientific community," says Dr. Du-shieng. Botanical drugs fundamentally work the same way as triple combination therapies for cancer or cocktail drugs for HIV. They hit multiple targets simultaneously with synergistic dynamics.